No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

byTeddy Guo

January 21, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

RelatedReports

Incidental findings common with breast imaging, often benign

Chronic Disease

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

August 21, 2025

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025

Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT

Increased close contact leads to spread of Andes virus in Argentina

#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

Oral azacytidine maintenance therapy improved survival outcomes in patients with acute myeloid leukemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

RELATED REPORTS

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

Increased close contact leads to spread of Andes virus in Argentina

RelatedReports

Recent Reports